Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

Portfolio Sees Dishman Exit in a Hurry as Customer Clovis Loses 70% Market Cap in the US

In a rapid descent into madness, Dishman Pharma fell over 12% today. It wasn’t a pretty sight, as the stock kept tanking through the day, while we tried ...

Like our content? Join Capitalmind Premium.

  • Equity, fixed income, macro and personal finance research
  • Model equity and fixed-income portfolios
  • Exclusive apps, tutorials, and member community
Subscribe Now Or start with a free-trial